Plasma Rich in Growth Factors (PRGF) for the Treatment of Lichen Sclerosus Atrophicus of the Vulva

Exclusion Criteria

• •Acute somatic disease
• •Infection in the intervention area or active systemic infection
• •History of cancerous or precancerous lesions in the intervention area
• •In active treatment with other local treatments in the intervention area
• •Under active treatment with immunosuppressants and/or anticoagulants
• •History of allergies to blood derivatives
• •Previous diagnosis of coagulopathies
• •Regular and continuous treatment with NSAIDs
• •Positive markers for HCV, AfHBs, HIV-I/II or PT
• •Pregnancy or women of childbearing age not taking contraceptive measures
• •Lactating women
• •Treatment with monoclonal antibodies
• •Liver failure
• •Any inability to participate in the study